{"id":"W2942062551","doi":"10.1358/dot.2019.55.4.2958476","title":"Encorafenib and binimetinib for the treatment of BRAFV600E/K-mutated melanoma","year":2019,"lang":"en","type":"review","venue":"Drugs of today","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Melanoma; MAPK/ERK pathway; Metastatic melanoma; V600E; Cancer research; Oncology; Kinase; Pharmacology; Mutation; Internal medicine; Biology; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001640626,0.0002940615,0.0009709999,0.00005510013,0.00003428814,0.000007779531,0.0002413012,0.0002784668,0.00001391288],"category_scores_gemma":[0.00003773209,0.00017175,0.0004958543,0.00006324753,0.0000930458,0.000001355437,0.0000575873,0.00004225244,0.000005411778],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001056369,"about_ca_system_score_gemma":0.0001692058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002629953,"about_ca_topic_score_gemma":0.000004151544,"domain_scores_codex":[0.9988687,0.00007058049,0.000446408,0.0003431583,0.0000905817,0.0001805841],"domain_scores_gemma":[0.9987227,0.0001963721,0.0004210942,0.0005441022,0.00006951325,0.00004627243],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005805655,0.0001342631,0.00001269964,0.004477916,0.0007244644,6.406922e-7,0.0001123598,5.592078e-7,0.001427988,0.0001280815,0.00102889,0.9918941],"study_design_scores_gemma":[0.0005617005,0.001286604,0.000005025081,0.0004350976,0.0008769166,0.000008492454,0.00002631469,0.000003086563,0.009883668,0.00001176365,0.9867259,0.0001754305],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001900736,0.9953208,0.00003871343,0.00001719992,0.0002678185,0.001279468,0.000521666,0.000004408757,0.0006492175],"genre_scores_gemma":[0.001099587,0.9959205,0.0002132488,0.00001056019,0.0001587375,0.0001398287,0.0005437486,0.00003913536,0.001874692],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9917186,"threshold_uncertainty_score":0.700376,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04074034639323368,"score_gpt":0.3182639523817377,"score_spread":0.277523605988504,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}